Effects of nicotine and vitamin E on glucose 6-phosphate dehydrogenase activity in some rat tissues in vivo and in vitro

ArticleAçık Erişim

Özet

Effects of nicotine, and nicotine + vitamin E on glucose 6-phosphate dehydrogenase (G-6PD) activity in rat muscle, heart, lungs, testicle, kidney, stomach, brain and liver were investigated in vivo and in vitro on partially purified homogenates. Supplementation period was 3 weeks (n = 8 rats per group): nicotine [0.5 mg/kg/day, intraperitoneal (ip)]; nicotine + vitamin E [75 mg/kg/day, intragastric (ig)]; and control group (receiving only vehicle). The results showed that nicotine (0.5 mg/kg, ip) inhibited G-6PD activity in the lungs, testicle, kidney, stomach and brain by 12.5% (p < 0.001), 48% (p < 0.001), 20.8% (p < 0.001), 13% (p < 0.001) and 23.35% (p < 0.001) respectively, and nicotine had no effects on the muscle, heart and liver G6PD activity. Also, nicotine + vitamin E inhibited G-6PD activity in the testicle, brain, and liver by 32.5% (p < 0.001), 21.5% (p < 0.001), and 16.5% (p < 0.001) respectively, and nicotine + vitamin E activated the muscle, and stomach G-6PD activity by 36% (p < 0.05), and 20% (p < 0.001) respectively. In addition, nicotine + vitamin E did not have any effects on the heart, lungs, and kidney G-6PD activity. In addition, in vitro studies were also carried out to elucidate the effects of nicotine and vitamin E on G-6PD activity, which correlated well with in vivo experimental results in lungs, testicles, kidney, stomach, brain and liver tissues. These results show that vitamin E administration generally restores the inactivation of G-6PD activity due to nicotine administration in various rat tissues in vivo, and also in vitro. © 2005 Taylor & Francis.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/16171Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1080/14756360500277384Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorGumustekin, Kenan
dc.contributor.authorCiftci, Mehmet
dc.contributor.authorCoban, Abdulkadir
dc.contributor.authorAltikat, Sayit
dc.contributor.authorAktas, Omer
dc.contributor.authorGul, Mustafa
dc.contributor.authorTimur, Handan
dc.contributor.authorDane, Senol
dc.date.accessioned2026-10-18T20:30:58.718381434Z
dc.date.available2026-10-18T20:30:58.718381434Z
dc.date.issued2005
dc.description.abstractEffects of nicotine, and nicotine + vitamin E on glucose 6-phosphate dehydrogenase (G-6PD) activity in rat muscle, heart, lungs, testicle, kidney, stomach, brain and liver were investigated in vivo and in vitro on partially purified homogenates. Supplementation period was 3 weeks (n = 8 rats per group): nicotine [0.5 mg/kg/day, intraperitoneal (ip)]; nicotine + vitamin E [75 mg/kg/day, intragastric (ig)]; and control group (receiving only vehicle). The results showed that nicotine (0.5 mg/kg, ip) inhibited G-6PD activity in the lungs, testicle, kidney, stomach and brain by 12.5% (p < 0.001), 48% (p < 0.001), 20.8% (p < 0.001), 13% (p < 0.001) and 23.35% (p < 0.001) respectively, and nicotine had no effects on the muscle, heart and liver G6PD activity. Also, nicotine + vitamin E inhibited G-6PD activity in the testicle, brain, and liver by 32.5% (p < 0.001), 21.5% (p < 0.001), and 16.5% (p < 0.001) respectively, and nicotine + vitamin E activated the muscle, and stomach G-6PD activity by 36% (p < 0.05), and 20% (p < 0.001) respectively. In addition, nicotine + vitamin E did not have any effects on the heart, lungs, and kidney G-6PD activity. In addition, in vitro studies were also carried out to elucidate the effects of nicotine and vitamin E on G-6PD activity, which correlated well with in vivo experimental results in lungs, testicles, kidney, stomach, brain and liver tissues. These results show that vitamin E administration generally restores the inactivation of G-6PD activity due to nicotine administration in various rat tissues in vivo, and also in vitro. © 2005 Taylor & Francis.
dc.identifier.doi10.1080/14756360500277384
dc.identifier.endpage502
dc.identifier.issn1475-6374
dc.identifier.issue5
dc.identifier.pmid16335059
dc.identifier.scopus2-s2.0-28244458827
dc.identifier.startpage497
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/16171
dc.identifier.volume20
dc.language.isoen
dc.relation.ispartofJournal of Enzyme Inhibition and Medicinal Chemistry
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGlucose 6-phosphate dehydrogenase
dc.subjectInactivation
dc.subjectInhibition
dc.subjectNicotine
dc.subjectRat tissues
dc.subjectVitamin E
dc.subjectAnimals
dc.subjectEnzyme Inhibitors
dc.subjectGlucosephosphate Dehydrogenase
dc.subjectOrgan Specificity
dc.subjectRats
dc.subjectRats, Sprague-Dawley
dc.subjectAnimalia
dc.subjectalpha tocopherol
dc.subjectglucose 6 phosphate dehydrogenase
dc.subjectanimal experiment
dc.subjectanimal tissue
dc.subjectarticle
dc.subjectbrain homogenate
dc.subjectcontrolled study
dc.subjectcorrelation function
dc.subjectdrug mechanism
dc.subjectenzyme activation
dc.subjectenzyme activity
dc.subjectenzyme inactivation
dc.subjectenzyme inhibition
dc.subjectheart
dc.subjectin vitro study
dc.subjectin vivo study
dc.subjectkidney homogenate
dc.titleEffects of nicotine and vitamin E on glucose 6-phosphate dehydrogenase activity in some rat tissues in vivo and in vitro
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus21
rdl.oa.statusopen
rdl.source.indexSCOPUS